Hematopoietic stem cell transplantation for people with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 5, 2016, Pages

  Oringanje, Chioma ^a   Nemecek, Eneida ^b   Oniyangi, Oluseyi ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NATIONAL HOSPITAL   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; BONE MARROW; EVENT FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; ANEMIA, SICKLE CELL; CHILD;

ANEMIA, SICKLE CELL; CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS;

EID: 84969543342     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007001.pub4     Document Type: Review

References (41)

1. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y, et al. Long term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007;110(7):2749-56.
2. Hongeng S, Pakakasama S, Chaisiripoomkere W, Chuansumrit A, Sirachainan N, Ungkanont A, et al. Outcome of transplantation with unrelated donor bone marrow in children with severe thalassaemia. Bone Marrow Transplantation 2004;33(4):377-9.
3. Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplantation 2005;35(2):171-7.
4. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, et al. Results of Minimally Toxic Non-myeloablative Transplanation in Patients with Sickle Cell Anemia and Beta-thalassemia. Biology of Blood and Marrow Transplantaion 2003;9(8):519-28.
5. Locatelli F, Vanderson R, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003;101(6):2137-43.
6. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, et al. Hematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation 2000;22(1):1-6.
7. Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995;85(4):879-84.
8. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, et al. Bone Marrow Transplantation for sickle cell disease. New England Journal of Medicine 1996;335(6):369-76.
9. Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation 2001;7(12):665-73.
10. Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, et al. Factors affecting thymic function after allogenic hematopoietic stem cell transplantation. Blood 2001;97(5):1458-63.
11. Adamkiewicz T, Mehta P, Boyer M, Kedar A, Olson T, Olson E, et al. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 2004;34(5):405-11.
12. Adams RJ, Mickie VC, Hsu L, Files B, Vichinsky E, Pegebo C, et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine 1998;339(1):5-11.
13. Artkins RC, Walter MC. Hematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opinion on Biological Therapy 2003;3(7):1-10.
14. Bernaudin F, Souillet G, Vannier JP, Plouvier E, Lemerle S, Michel G, et al. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO. Bone Marrow Transplant 1993;12(Suppl):118-21.
15. Bernaudin F, Souillet G, Vannier JP, Vilmer E, Michel G, Lutz P, et al. Report of the French experience concerning 26 children transplanted for severe sickle cell disease. Bone Marrow Transplant 1997;19(Suppl):112-4.
16. Brichard B, Vermylen C, Ninane J, Cornu G. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in patients with sickle cell anaemia. Journal of Pediatrics 1996;128(2):241-3.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
18. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(1079):629-34.
19. Giardini C, Galimberti M, Lucarrelli G, Polchi P, Angelucci E, Baronciani D, et al. Bone marrow transplantation in sickle cell disorders in Pesaro. Bone Marrow Transplant 1993;12(Suppl 1):122-3.
20. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
21. Jacobsohn DA, Duerst R, Tse W, Kletzel M. Reduced intensity hematopoietic stem-cell transplantation. Lancet 2004;364(9429):156-62.
22. Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biology of Blood and Marrow Transplantation 2005;11(5):349-53.
23. Johnson FL, Look AT, Gockerman J, Ruggiero MR, Dalla-pozza L, Billings FT. Bone marrow transplantation in a patient with sickle cell anaemia. New England Journal of Medicine 1984;311(12):780-3.
24. Jones AP, Davies SC, Olujohungbe A. Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD002202]
25. Lane PA, Nuss R, Ambruso D. Hematologic disorders. In: Hay WW, Hayward AR, Levin MJ, Sondheimer JM editor(s). Current Pediatric Diagnosis and Treatment. 15th Edition. New York: McGraw-Hill Companies Inc, 2001:756-9.
26. London Health Science Center. Bone Marrow Transplant. Updated 2003. www.ihsc.on.ca/transplant/bnmarrow.htm (accessed 2 October 2007).
27. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Bone marrow transplantation in adults thalassemic patients. Blood 1999;93(4):1164-7.
28. Milpied NHJ, Garand R, David A. Bone marrow transplantation for sickle cell anaemia (letter). Lancet 1988;2(8606):328-9.
29. Modell B, Darlinson M. Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 2008;86(6):480-7.
30. Nietert PJ, Abbound MR, Silverstein MR, Jackson SM. Bone marrow transplantation versus periodic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 2000;95(10):3057-64.
31. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease - life expectancy and risk factors for early death. New England Journal of Medicine 1994;330(23):1639-43.
32. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
33. Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd Edition. Oxford: Oxford University Press, 2001.
34. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, et al. Chronic graft-versus-host-disease and other late complications of bone marrow transplantation. Seminars in Hematology 1991;28(3):250-9.
35. van Besien K, Bartholowmew A, Stock W, Peace D, Devine S, Sher D, et al. Fludarabine-based conditioning for allogenic transplantation in adults with sickle cell disease. Bone Marrow Transplantation 2000;26(4):445-9.
36. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A, et al. Hematopoietic stem cell transplantation forsickle cell anemia: the first 50 patients transplanted in Belgium. Bone Marrow Tranplant 1998;22:1-6.
37. Vermylen C. Hematopoietic stem cell transplantation in sickle cell disease. Blood Reviews 2003;17(3):163-6.
38. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease; an interim report. Blood 2000;95(6):1918-24.
39. Walters MC, Patience M, Leisenring W, et al. Updated results of bone marrow transplantation (BMT) for sickle cell disease (SCD): impact on CNS disease. Blood 2002;100:45a-46a.
40. Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for children with sickle cell disease. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007001.pub2]
41. Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for people with sickle cell disease. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD007001.pub3]